Hong Kong Sanatorium & Hospital (HKSH) has passed the drug clinical trial institution qualification examination by National Medical Product Administration (formerly CFDA) and the Government of the Hong Kong Special Administrative Region’s Department of Health Review in which the hospital is now authorized as the entrusted institute for drug registration and can carry out the clinical trials approved by National Medical Product Administration.
Medical institute and the expertise verified through clinical qualification examination
Institutional name | Qualified specialty |
Hong Kong Sanatorium & Hospital (HKSH) | Comprehensive oncology |
Prince of Wales Hospital, Queen Mary Hospital and Hong Kong Eye Hospital within the Hong Kong Special Administrative Region have passed the clinical trial institution review and evaluation where the hospital is now authorized as the entrusted institute for drug registration and can carry out the clinical trials approved by National Medical Product Administration.
Medical institute and the expertise verified through clinical review and evaluation
Institutional name | Qualified specialty |
Prince of Wales Hospital | Digestion, tumor, endocrine, cardiovascular, pediatric blood, pediatric respiratory, pediatric immunization, pediatric infection, bioequivalence test, hematology, urology, anesthesiology and intensive therapy, otolaryngology-head and neck surgery, obstetrics and gynecology, cranial nerve internal medicine, Phase I Clinical Research Center (clinical research) |
Queen Mary Hospital | Cardiovascular, endocrine, respiratory, hepatobiliary-pancreatic surgery and liver transplantation, maternity and fertility regulation, blood and bone marrow transplantation, neurology, nephrology, immunology, orthopedics, liver-spleen-stomach internal medicine, oncology, pediatrics, hospital wards for phase I clinical trial |
Hong Kong Eye Hospital | Ophthalmology |